announces the marketing launch of the Comfort Patch

The COMFORT PATCH is in Patent Pending status within the United States Patent and Trademark Office. Global Invention Royalty Analysis was performed by World Patent Marketing (
Aug. 11, 2014 - PRLog -- The present invention relates generally to a topically-administered medication. More specifically, the present invention is a wearable transdermal patch that is utilized to deliver analgesic medication into the user’s system through the user’s skin for continued medication administration over an extended period of time.

Pain management is often required for a variety of reasons. Such as, during recovery in the aftermath of a medical procedure or following an injury. Additionally, pain management is sought for minor occurrences such as headaches and cramps. Two of the most common over-the-counter analgesic drugs utilized for pain management are Acetaminophen and Ibuprofen. When used for minor discomfort and pain, pain relief medication is most commonly administered via ingesting the medication in pill, tablet, or capsule form. It is generally recommended that the appropriate dosage of medication be taken again periodically throughout the day in the case of persistent symptoms. Proper care must be taken to ensure proper dosage for a particular person in order to avoid overdose. There is a wide variety of routes of administration for pain relief medication. Solid forms of medication can be difficult to administer, particularly if the user has trouble swallowing a solid object, even with the assistance of fluid. Children are additionally averse to swallowing medication in solid form and as such, it can be difficult to administer needed pain relief medication to children. Alternative routes of administration are available such as syrups that may be taken orally. However, these medications often feature a very unpleasant taste and as such, children may resist these alternative types of medication as well. The present invention seeks to address the aforementioned issues relating to pain relief medication administration as well as provide users with a convenient, practical, and straightforward solution.

The present invention is a transdermal patch that delivers analgesic medication through the user’s skin. In the preferred embodiment of the present invention, the transdermal patch is wearable on the user’s body and delivers medication directly through the user’s skin and into the user’s bloodstream. The transdermal patch serves to provide continued release of medication into the user’s system over an extended period of time in order to eliminate the need to administer additional dosages of medication. The transdermal patch is multilayered and comprises a drug reservoir that contains the analgesic drug for transdermal administration. The drug reservoir is secured to a drug-release membrane that controls the rate of administration of the drug through the user’s skin. The transdermal patch further comprises an adhesive for attaching and holding the transdermal patch in place on the user’s skin. The uppermost layer of the transdermal patch comprises a backing layer that is impermeable to prevent the analgesic drug from entering into the backing layer. In the preferred embodiment of the present invention, the upper surface of the backing layer comprises a location on which the user may write the date and time at which the transdermal patch is applied to the skin and drug administration begins. Finally, the lowermost layer of the transdermal patch is removable and comprises a protective release liner. The release liner may be removed from the transdermal patch in order to expose the adhesive and allow the user to place the transdermal patch onto his or her skin. The drug is administered through the drug-release membrane. The drug-release membrane controls the rate of administration into the user’s bloodstream.

The transdermal patch of the present invention is available in a number of configurations relating generally to the dosage of the analgesic drug. The transdermal patch may vary in terms of size in order to provide lower dosages for children as well as increased dosages for adults. Additionally, the present invention is not limited with respect to the specific physical design of the transdermal patch and as such, the transdermal patch may vary in terms of shape as well as size.

The inventor of the COMFORT PATCH is seeking a third party licensee to manufacture, market and distribute the product for him under a royalty agreement. Potential licensees in the appropriate industries are currently being targeted as candidates to eventually commercialize the COMFORT PATCH on a worldwide basis.

According to a comprehensive university study brokered by World Patent Marketing, there is a strong likelihood of this product being successful in the marketplace.

Potential licensees interested in obtaining more information about the COMFORT PATCH and discussing licensing opportunities with respect to the product can contact the Licensing Department of at or 646-412-5985

Bill Flanagan
Email:*** Email Verified
Tags:Patent, Patent Agent, Patent Attorney, Prototype, Licensing
Industry:Health, Medical
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Page Updated Last on: Aug 26, 2014

Like PRLog?
Click to Share